0
0
0
s2sdefault

The Food and Drug Administration has failed to approve a single reduced-harm nicotine product in the past year, despite unveiling a new “roadmap” in July 2017 that emphasized the role such products can play a reducing tobacco-related illness. That lapse does a huge disservice to millions of smokers who could benefit from switching from cigarettes to a far less harmful product. A year ago, the FDA claimed it would balance regulation against encouraging the development of harm-reducing products. [...]